The Glasgow Coma Scale is a widespread and important tool for discussing conscious level. After all, "what's the GCS?", barked the stereotypical neurosurgeon at the cowering FY1. But why?!
Well, I can't answer that. But let's think about the GCS in this #tweetorial. #MedEd 1/15
In case anyone feels like signing… an open letter from a collaborator to try and get nanopore sequencing as standard for brain tumours. @UoS_WISHlab 👇👇👇👇👇👇👇👇👇👇 britishneuropathologicalsoci…
Our review is now out in Lancet Neurology on "Crossing the Blood–Brain Barrier: Emerging Therapeutic Strategies for Neurological Disease". We highlight several pioneering strategies that show promise for safely bypassing this barrier. authors.elsevier.com/a/1kUHI…
NEWS | @LivUni scientists and collaborators have highlighted the most effective treatments for neurological diseases by overcoming one of medicine’s most difficult challenges: the blood–brain barrier🩸
Read more ⬇️
news.liverpool.ac.uk/2025/01…
ALT An illustration of a head and brain with text overlaid that reads, 'NEWS: Revealing insights into neurological disease treatment'
Here are 10 things that expert clinicians do everyday, often without realizing it🩺
(and how we can all start to implement these in our own practice)
A 🧵
#foamed#MedTwitter
For anyone worried today about #colloidcysts after @ThisisDavina underwent surgery, here’s some info
They are quite uncommon, often found by chance (incidental)
They are benign cysts rather than tumours
Most do not cause symptoms, don’t grow and never require surgery (some do!)
🧠 ⭐️PhD Opportunity!⭐️🧬
Are you interested in Brain Cancer and Neuroscience? Want to study in a world-leading university? Look no further than this #CR_UK studentship at #UCLcolcc.ac.uk/2025-phd-project…
Thank you to @NHSEngland FOI team for this information on the total number of unique applicants for CT1/ST1 training this year.
26,036 doctors applied for 9,331 posts - overall competition ratio 2.79:1.
There is no shortage of doctors. We just don't want to train them.
We’re so pleased to announce that our Glioblastoma (Brain Cancer) Fund has reached its initial £250,000 target 👏 🎉
The campaign currently funds ground-breaking research into immunotherapy, a promising new treatment for brain cancer. (1/2)
Here's the next episode of @NPodcases Neuroscience Research Specials!
@RCSnews Prof Michael Jenkinson on meningioma, trials, and the importance of a good acronym!
Spotify - spoti.fi/4784tYB
SoundCloud - bit.ly/3Mr4Yn0
Apple Podcasts - apple.co/478sYVq